On April 18, 2022, leaders such as Zhu Chaoping, deputy director of Nanjing Science and Technology Bureau, Lu Jing, deputy head of Qixia District, and Yang Jing, full-time deputy secretary of Qixia High-tech Industrial Development Zone, visited our company. Zhang Yuji, general manager of our company, and senior executives gave a warm reception.

The general manager of Liding Medical communicated with the delegation of our city

Zhang Yuji, general manager of Liding Medical, briefly reported the company's current situation and development plan, and focused on the company's core technology and achievement transformation. At present, the second phase of research and development is under construction, and the supporting P2-level biosafety laboratory will assist in the evaluation of vaccines/new coronavirus antiviral drugs.

The general manager of Liding Medical reported the current situation and development plan of the company

During the meeting, Director Zhu focused on the work progress of Liding Medical's new crown series products, and praised Liding Medical's domestic substitution of imports and the technology of core raw materials to solve the problem of neck stuck.

During this visit, the leaders of the city were full of affirmation for the development of Liding Medical. Liding will also make unremitting efforts, unswervingly promote innovation, develop better products, and strive to become a leader in overall solutions in the biopharmaceutical industry.

Liding always adheres to the corporate mission of "allowing every life to obtain more accurate diagnosis and treatment"